1-4 of 4
Omer Ashruf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Disease-specific safety and efficacy of doacs vs. LMWH for venous thromboembolism in patients with brain metastases: A real-world trinetx analysis

Free
Ali Mushtaq, Omer Ashruf, Mohanad Baroudi, Ahmad Safdar, Alok Khorana, Dana Angelini
Journal: Blood
Blood (2025) 146 (Supplement 1): 1360.
https://doi.org/10.1182/blood-2025-1360
Published: 2025
Journal Articles

Major adverse cardiovascular events (MACE) in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: A target trial emulation study

Free
Omer Ashruf, Henyah Dardir, Ankit Patel, Emily Moncher, Nandhini Ravichandran, David Kaelber, Sophia Balderman, Anjali Advani, John Molina, Moaath Mustafa Ali, Aaron Gerds, Hetty Carraway, Faiz Anwer, Abhay Singh, Sudipto Mukherjee, Larry Cripe, Akriti Jain
Journal: Blood
Blood (2025) 146 (Supplement 1): 4627.
https://doi.org/10.1182/blood-2025-4627
Published: 2025
Journal Articles

Comparative risk of major adverse cardiovascular events in polycythemia vera patients treated with ruxolitinib, hydroxyurea, or interferon: A real-world, propensity-matched cohort study

Free
Ali Mushtaq, Omer Ashruf, Larry Cripe, Abhay Singh, John Molina, Hetty Carraway, Sudipto Mukherjee, Aaron Gerds, Akriti Jain
Journal: Blood
Blood (2025) 146 (Supplement 1): 3826.
https://doi.org/10.1182/blood-2025-3826
Published: 2025
Journal Articles

Clinical Outcomes and Disease Progression after Daratumumab-Based Treatment in Primary Amyloidosis

Free
Omer Ashruf, Ali Mushtaq, Faiza Zakaria, Razwana Khanam, Faiz Anwer
Journal: Blood
Blood (2024) 144 (Supplement 1): 1924.
https://doi.org/10.1182/blood-2024-211663
Published: 2024